{"product_id":"ss-31-10mg-vial","title":"SS-31 50mg vial","description":"\u003cp data-end=\"422\" data-start=\"268\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                         \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"422\" data-start=\"268\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003cstrong data-is-only-node=\"\" data-end=\"9\" data-start=\"0\"\u003eSS-31\u003c\/strong\u003e, also known as \u003cstrong data-end=\"41\" data-start=\"25\"\u003eElamipretide\u003c\/strong\u003e, is a synthetic tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH₂) designed to target and stabilize mitochondrial function.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eBy selectively binding to cardiolipin—a phospholipid unique to the inner mitochondrial membrane—SS-31 aims to preserve mitochondrial integrity, enhance bioenergetics, and mitigate oxidative stress.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eThis mechanism positions SS-31 as a promising therapeutic candidate for a range of conditions associated with mitochondrial dysfunction, including neurodegenerative diseases, cardiovascular disorders, and metabolic syndromes.\u003c\/span\u003e\u003cspan class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[0.5625em] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" rel=\"noopener\" href=\"https:\/\/www.alzdiscovery.org\/uploads\/cognitive_vitality_media\/SS-31-Cognitive-Vitality-For-Researchers.pdf?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between absolute\"\u003e\u003cspan class=\"-me-1 flex h-full items-center rounded-full px-1 text-[#8F8F8F]\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"427\" data-start=\"424\"\u003e\n\u003ch2 data-end=\"458\" data-start=\"429\"\u003e\u003cstrong data-end=\"458\" data-start=\"432\"\u003e2. Mechanism of Action\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-end=\"496\" data-start=\"460\"\u003e\u003cstrong data-end=\"496\" data-start=\"464\"\u003e2.1. Mitochondrial Targeting\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"656\" data-start=\"498\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eSS-31 exhibits high affinity for cardiolipin, facilitating its accumulation within the inner mitochondrial membrane.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eThis localization allows SS-31 to exert its effects directly at the site of electron transport and ATP synthesis.\u003c\/span\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003c\/span\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"695\" data-start=\"658\"\u003e\u003cstrong data-end=\"695\" data-start=\"662\"\u003e2.2. Bioenergetic Enhancement\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"855\" data-start=\"697\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eBy stabilizing cardiolipin, SS-31 supports the optimal function of the electron transport chain (ETC), leading to improved ATP production and reduced electron leak.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eThis enhancement of mitochondrial efficiency is crucial in tissues with high energy demands.\u003c\/span\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"892\" data-start=\"857\"\u003e\u003cstrong data-end=\"892\" data-start=\"861\"\u003e2.3. Antioxidant Properties\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1052\" data-start=\"894\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eSS-31 possesses intrinsic antioxidant capabilities, scavenging reactive oxygen species (ROS) and reducing oxidative damage to mitochondrial components.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eThis action helps in maintaining mitochondrial integrity and function under stress conditions.\u003c\/span\u003e \u003c\/p\u003e\n\u003chr data-end=\"1057\" data-start=\"1054\"\u003e\n\u003ch2 data-end=\"1103\" data-start=\"1059\"\u003e\u003cstrong data-end=\"1103\" data-start=\"1062\"\u003e3. Clinical Applications and Efficacy\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-end=\"1141\" data-start=\"1105\"\u003e\u003cstrong data-end=\"1141\" data-start=\"1109\"\u003e3.1. Cardiovascular Diseases\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1381\" data-start=\"1143\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eIn preclinical models, SS-31 has demonstrated cardioprotective effects, including improved myocardial function and reduced infarct size following ischemia-reperfusion injury.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eHowever, clinical trials have yielded mixed results.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eFor instance, a phase 2 trial in patients with heart failure with reduced ejection fraction did not meet its primary endpoints, though some secondary measures indicated potential benefits.\u003c\/span\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"1432\" data-start=\"1383\"\u003e\u003cstrong data-end=\"1432\" data-start=\"1387\"\u003e3.2. Primary Mitochondrial Myopathy (PMM)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1592\" data-start=\"1434\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eSS-31 has been evaluated in patients with PMM, a group of disorders characterized by impaired mitochondrial function.\u003c\/span\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eWhile early-phase studies suggested improvements in exercise tolerance and mitochondrial biomarkers, a larger phase 3 trial failed to achieve its primary efficacy outcomes.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-end=\"1633\" data-start=\"1594\"\u003e\u003cstrong data-end=\"1633\" data-start=\"1598\"\u003e3.3. Age-Related Muscle Decline\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1793\" data-start=\"1635\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eIn aged animal models, SS-31 treatment has been associated with enhanced mitochondrial function, improved muscle endurance, and reduced oxidative stress.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eThese findings suggest potential applications in mitigating age-related sarcopenia and improving physical performance in the elderly.\u003c\/span\u003e \u003c\/p\u003e\n\u003ch3 data-end=\"1834\" data-start=\"1795\"\u003e\u003cstrong data-end=\"1834\" data-start=\"1799\"\u003e3.4. Neurodegenerative Diseases\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1994\" data-start=\"1836\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003ePreclinical studies have indicated that SS-31 may offer neuroprotective effects by preserving mitochondrial function and reducing oxidative damage in models of neurodegenerative diseases such as Alzheimer's and Parkinson's.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eHowever, clinical validation in human subjects remains to be established.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"1999\" data-start=\"1996\"\u003e\n\u003ch2 data-end=\"2034\" data-start=\"2001\"\u003e\u003cstrong data-end=\"2034\" data-start=\"2004\"\u003e4. Safety and Tolerability\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"2154\" data-start=\"2036\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eSS-31 has generally been well-tolerated in clinical studies.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eThe most commonly reported adverse events include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul data-end=\"2376\" data-start=\"2156\"\u003e\n\u003cli data-end=\"2227\" data-start=\"2156\"\u003e\n\u003cp data-end=\"2227\" data-start=\"2158\"\u003e\u003cstrong data-end=\"2186\" data-start=\"2158\"\u003eInjection site reactions\u003c\/strong\u003e: \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eRedness, pain, or swelling at the site of administration.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2376\" data-start=\"2228\"\u003e\n\u003cp data-end=\"2376\" data-start=\"2230\"\u003e\u003cstrong data-end=\"2256\" data-start=\"2230\"\u003eHeadache and dizziness\u003c\/strong\u003e: \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eOccasionally reported but typically mild in severity.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2536\" data-start=\"2378\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eNo serious adverse events directly attributable to SS-31 have been consistently observed.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eHowever, long-term safety data are limited, and further studies are needed to fully assess the risk profile.\u003c\/span\u003e \u003c\/p\u003e\n\u003chr data-end=\"2541\" data-start=\"2538\"\u003e\n\u003ch2 data-end=\"2569\" data-start=\"2543\"\u003e\u003cstrong data-end=\"2569\" data-start=\"2546\"\u003e5. Pharmacokinetics\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"2843\" data-start=\"2571\"\u003e\n\u003cli data-end=\"2632\" data-start=\"2571\"\u003e\n\u003cp data-end=\"2632\" data-start=\"2573\"\u003e\u003cstrong data-end=\"2591\" data-start=\"2573\"\u003eAdministration\u003c\/strong\u003e: \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003ePrimarily via subcutaneous or intravenous injection.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2691\" data-start=\"2633\"\u003e\n\u003cp data-end=\"2691\" data-start=\"2635\"\u003e\u003cstrong data-end=\"2648\" data-start=\"2635\"\u003eHalf-life\u003c\/strong\u003e: \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eApproximately 4 hours in animal models; human pharmacokinetic data are still being elucidated.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2843\" data-start=\"2692\"\u003e\n\u003cp data-end=\"2843\" data-start=\"2694\"\u003e\u003cstrong data-end=\"2717\" data-start=\"2694\"\u003eTissue Distribution\u003c\/strong\u003e: \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eRapid uptake into mitochondria-rich tissues, including cardiac and skeletal muscle.\u003c\/span\u003e \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2848\" data-start=\"2845\"\u003e\n\u003ch2 data-end=\"2877\" data-start=\"2850\"\u003e\u003cstrong data-end=\"2877\" data-start=\"2853\"\u003e6. Regulatory Status\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"3045\" data-start=\"2879\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eSS-31 (Elamipretide) is currently under clinical investigation and has not yet received regulatory approval for general medical use.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eIt is being developed by Stealth BioTherapeutics and has been granted orphan drug designation for certain mitochondrial diseases.\u003c\/span\u003e \u003cspan class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[0.5625em] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" rel=\"noopener\" href=\"https:\/\/www.alzdiscovery.org\/uploads\/cognitive_vitality_media\/SS-31-Cognitive-Vitality-For-Researchers.pdf?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between overflow-hidden\"\u003e\u003cspan class=\"max-w-full grow truncate overflow-hidden text-center\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"3050\" data-start=\"3047\"\u003e\n\u003ch2 data-end=\"3072\" data-start=\"3052\"\u003e\u003cstrong data-end=\"3072\" data-start=\"3055\"\u003e7. Conclusion\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"3240\" data-start=\"3074\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eSS-31 represents a novel approach to targeting mitochondrial dysfunction, a central feature in numerous chronic diseases.\u003c\/span\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eWhile preclinical studies have demonstrated promising results across various models, clinical trials have produced mixed outcomes.\u003c\/span\u003e \u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eFurther research is necessary to fully understand its therapeutic potential and to identify patient populations that may benefit most from its application.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-end=\"3245\" data-start=\"3242\"\u003e\n\u003cp data-end=\"3262\" data-start=\"3247\"\u003e\u003cstrong data-end=\"3262\" data-start=\"3247\"\u003eReferences:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"3778\" data-start=\"3264\"\u003e\n\u003cli data-end=\"3391\" data-start=\"3264\"\u003e\n\u003cp data-end=\"3391\" data-start=\"3267\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eMitchell, W., et al. (2020). The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action. \u003cem data-end=\"207\" data-start=\"174\"\u003eJournal of Biological Chemistry\u003c\/em\u003e, 295(21), 7452–7469.\u003c\/span\u003e \u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3520\" data-start=\"3393\"\u003e\n\u003cp data-end=\"3520\" data-start=\"3396\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eKaraa, A., et al. (2020). Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. \u003cem data-end=\"133\" data-start=\"122\"\u003eNeurology\u003c\/em\u003e, 94(7), e740–e751.\u003c\/span\u003e \u003cspan class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[0.5625em] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" rel=\"noopener\" href=\"https:\/\/www.alzdiscovery.org\/uploads\/cognitive_vitality_media\/SS-31-Cognitive-Vitality-For-Researchers.pdf?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between absolute\"\u003e\u003cspan class=\"-me-1 flex h-full items-center rounded-full px-1 text-[#8F8F8F]\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3649\" data-start=\"3522\"\u003e\n\u003cp data-end=\"3649\" data-start=\"3525\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eSiegel, M. P., et al. (2013). Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice. \u003cem data-end=\"161\" data-start=\"149\"\u003eAging Cell\u003c\/em\u003e, 12(5), 763–771.\u003c\/span\u003e \u003cspan class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"\u003e\u003ca class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[0.5625em] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" rel=\"noopener\" href=\"https:\/\/medisearch.io\/blog\/ss-31-peptide-benefits-safety-and-side-effects?utm_source=chatgpt.com\" target=\"_blank\"\u003e\u003cspan class=\"relative start-0 bottom-0 flex h-full w-full items-center\"\u003e\u003cspan class=\"flex h-4 w-full items-center justify-between absolute\"\u003e\u003cspan class=\"-me-1 flex h-full items-center rounded-full px-1 text-[#8F8F8F]\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3778\" data-start=\"3651\"\u003e\n\u003cp data-end=\"3778\" data-start=\"3654\"\u003e\u003cspan class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"\u003eZhao, K., et al. (2004). Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. \u003cem data-end=\"213\" data-start=\"180\"\u003eJournal of Biological Chemistry\u003c\/em\u003e, 279(33), 34682–34690.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684859375954,"sku":null,"price":150.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/ss-31_50mg.png?v=1770834895","url":"https:\/\/sciencepeptideslab.com\/products\/ss-31-10mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}